Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplant with DLI for Metastatic Renal Cell Carcinoma
NCT00025519Phase 2Withdrawn
- Sponsor
- Fox Chase Cancer Center
- Start
- Jun 2001
- Primary completion
- Oct 2006
- Modality
- Cell Therapies
01
Overview
A Phase 2 trial of therapeutic allogeneic lymphocytes in renal cell carcinoma (RCC), sponsored by Fox Chase Cancer Center. Planned start Jun 2001; status: withdrawn.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00025519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025519.